Finance

Lists
Why is RMD up 2.56%?
Dive Deeper
RMD:ASX
Resmed CDI
AU$36.41
+2.56%
(+0.91) 1D
ኖቬም 19, 4:21:14 ከሰዓት ጂ ኤም ቲ+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RMD...
Open
AU$35.88
High
AU$36.46
Low
AU$35.81
Mkt. cap
34.12 ቢ
Avg. vol.
1.91 ሚ
Volume
1.44 ሚ
52-wk high
AU$39.94
52-wk low
AU$25.50
Shares outstanding
140.66 ሚ
No. of employees
11 ሺ
Open
AU$35.88
High
AU$36.46
Low
AU$35.81
Mkt. cap
34.12 ቢ
Avg. vol.
1.91 ሚ
Volume
1.44 ሚ
52-wk high
AU$39.94
52-wk low
AU$25.50
Shares outstanding
140.66 ሚ
No. of employees
11 ሺ
News stories
From web sources and news partners
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed CDI
CEOMichael J. Farrell
Employees11.4 ሺ
Foundedጁን 1989
Headquartersሳንዲየጎ, ካሊፎርኒያ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryMedical device
Websiteresmed.com
Last report
29 ኦክቶ 2026
Fiscal period
Q1 2027
US$0.29 / US$0.27
+8.81%beat
Revenue / Est. (USD)
1.41 ቢ / 1.39 ቢ
+1.55%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
1.42 ቢ
1.43 ቢ
1.46 ቢ
1.41 ቢ
Cost of goods sold
536.28 ሚ
532.58 ሚ
594.13 ሚ
536.45 ሚ
Cost of revenue
536.28 ሚ
532.58 ሚ
594.13 ሚ
536.45 ሚ
Research and development expenses
90.97 ሚ
94.27 ሚ
105.72 ሚ
101.53 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
275.70 ሚ
279.80 ሚ
293.36 ሚ
284.20 ሚ
Operating expense
386.24 ሚ
393.16 ሚ
417.88 ሚ
385.73 ሚ
Total operating expenses
922.51 ሚ
925.74 ሚ
1.01 ቢ
922.18 ሚ
Operating income
500.30 ሚ
505.67 ሚ
451.64 ሚ
492.64 ሚ
Other non operating income
42.00 ሺ
181.00 ሺ
4.40 ሚ
2.95 ሚ
EBT including unusual items
496.15 ሚ
502.31 ሚ
474.16 ሚ
539.16 ሚ
EBT excluding unusual items
504.48 ሚ
518.30 ሚ
476.09 ሚ
511.31 ሚ
Income tax expense
103.56 ሚ
103.58 ሚ
90.73 ሚ
120.74 ሚ
Effective tax rate
20.87%
20.62%
19.14%
22.39%
Other operating expenses
-
-
-
-
Net income
392.59 ሚ
398.73 ሚ
383.43 ሚ
418.41 ሚ
Net profit margin
27.59%
27.86%
26.20%
29.57%
Earnings per share
2.81
0.29
0.30
0.29
Interest and investment income
4.46 ሚ
3.80 ሚ
31.76 ሚ
21.20 ሚ
Interest expense
-
-
-
-4.81 ሚ
Net interest expenses
4.46 ሚ
3.80 ሚ
31.76 ሚ
16.38 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
543.79 ሚ
558.22 ሚ
490.13 ሚ
534.38 ሚ
Gain or loss from assets sale
-
-
-
-61.78 ሚ
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች